
Cefalexin is a premium-grade, white to off-white crystalline powder first-generation cephalosporin antibiotic compound carrying CAS number 15686-71-2. Refined under strict pharmaceutical quality compliance, this high-purity therapeutic substance exhibits exceptional bactericidal performance through cell wall synthesis inhibition. Therefore, it provides reliable efficacy across diverse respiratory and urinary tract infection formulations. Consequently, it serves as an ideal core choice for manufacturing specialized oral pharmaceutical syrups, advanced capsules, and modern clinical antibiotic therapeutic lines globally.
Excellent crystalline solubility performance in aqueous solutions provides a distinct operational edge. In addition, its outstanding biological affinity delivers swift results when engineering modern fast-acting antibiotic formulations. This active organic solid operates by binding to penicillin-binding proteins (PBPs) within bacterial cell walls systematically. Thus, it successfully enhances the bactericidal profiling of targeted medicinal matrices.
Clearly, it supplies the exact chemical mechanisms required to induce rapid therapeutic effects. As a consequence, it achieves this antimicrobial action without altering raw mass density uniformity. Therefore, manufacturing teams can count on highly predictable batch results during formulation runs. In this way, processing parameters remain fully stable across diverse commercial production lines.
Moreover, it assists processing engineers in maintaining strict active concentration uniformity. This chemical balance is critical across high-speed liquid mechanical blending and automated syrup filling lines. Hence, it mitigates trace precipitation risks within automated volumetric dosing machinery. For instance, specialized manufacturing facilities incorporate this refined organic powder safely.
Specifically, it acts as a core compound in targeted respiratory medicine and specialized pediatric syrup production cycles. Consequently, it maximizes the technical throughput of automated formulation machinery. Consequently, Zyntex coordinates clean room synthesis paths to eliminate downstream moisture-induced alterations from your factory schedule. As a result, your operational lines suffer zero delays from crystal caking or compound degradation.
This high-purity crystalline active therapeutic compound delivers crucial technical value within these four primary industrial sectors:
Primary antibiotic source used for formulating high-efficiency bacterial infection control liquids.
Utilized as a high-purity active base to compound professional clinical-strength capsules and tablets.
Acts as an essential active standard for manufacturing specialized chronic infection management formulations.
Used as a professional reference material for validating advanced antimicrobial activity kinetics.
| Parameter | Standard Value |
|---|---|
| Product Name | Cefalexin (Sefaleksin) |
| Assay / Purity | Min 95.0% – 101.0% (Pharma Grade) |
| Appearance | White, crystalline powder |
| CAS Number | 15686-71-2 |
⚠️ DANGER / Safety & Handling: Cefalexin is a stable therapeutic compound, but may cause allergic sensitization or respiratory irritation upon dust inhalation. Avoid direct skin contact and ocular exposure. Store in original sealed containers in a cool, dry area away from heat. Use appropriate PPE, including gloves and particulate masks, during handling. Review the Safety Data Sheet (SDS) for detailed protocols.